Rare Voices Australia (RVA) welcomes the ‘Procedure guidance for medicines funded through the Life Saving Drugs Program (LSDP) - Version 1.0,’ which has been published on the Department of Health website. RVA has been a strong advocate for reform of the LSDP and a key participant (alongside the Department of Health and industry representatives) in the development of this procedural reform detail. The Procedure Guidance covers many aspects of the LSDP including the consideration of new medicines and medicine reviews. We congratulate all involved in its development.
You can read RVA's full response here.